Many
attempts have been made to synthesize cadmium-free quantum
dots (QDs), using nontoxic materials, while preserving their unique
optical properties. Despite impressive advances, gaps in knowledge
of their intracellular fate, persistence, and excretion from the targeted
cell or organism still exist, precluding clinical applications. In
this study, we used a simple model organism (Hydra
vulgaris) presenting a tissue grade of organization
to determine the biodistribution of indium phosphide (InP)-based QDs
by X-ray fluorescence imaging. By complementing elemental imaging
with In L-edge X-ray absorption near edge structure, unique information
on in situ chemical speciation was obtained. Unexpectedly, spectral
profiles indicated the appearance of In–O species within the
first hour post-treatment, suggesting a fast degradation of the InP
QD core in vivo, induced mainly by carboxylate groups. Moreover, no
significant difference in the behavior of bare core QDs and QDs capped
with an inorganic Zn(Se,S) gradient shell was observed. The results
paralleled those achieved by treating animals with an equivalent dose
of indium salts, confirming the preferred bonding type of In3+ ions in Hydra tissues. In conclusion, by focusing
on the chemical identity of indium along a 48 h long journey of QDs
in Hydra, we describe a fast degradation process,
in the absence of evident toxicity. These data pave the way to new
paradigms to be considered in the biocompatibility assessment of QD-based
biomedical applications, with greater emphasis on the dynamics of
in vivo biotransformations, and suggest strategies to drive the design
of future applied materials for nanotechnology-based diagnosis and
therapeutics.